Kohlruss, Meike
Krenauer, Marie
Grosser, Bianca
Pfarr, Nicole http://orcid.org/0000-0002-5977-5375
Jesinghaus, Moritz http://orcid.org/0000-0002-0018-5661
Slotta-Huspenina, Julia
Novotny, Alexander
Hapfelmeier, Alexander
Schmidt, Thomas
Steiger, Katja http://orcid.org/0000-0002-7269-5433
Gaida, Matthias M.
Reiche, Magdalena
Bauer, Lukas
Ott, Katja
Weichert, Wilko
Keller, Gisela http://orcid.org/0000-0003-2886-0371
Funding for this research was provided by:
Deutsche Krebshilfe (70112177, 70112380, 70112380, 70112177, 70112177)
Wilhelm Sander-Stiftung (2019.156.1)
Article History
Received: 22 July 2021
Revised: 28 September 2021
Accepted: 5 October 2021
First Online: 20 October 2021
Ethics approval and consent to participate
: The use of tissue samples was approved by the local Institutional Review Boards at the Technical University Munich (reference: 502/15s) and at the University of Heidelberg (reference: 301/2001). The participants had given informed consent. All experiments were performed in accordance with the Declaration of Helsinki.
: Not applicable.
: WW has a consulting role for AZ, Takeda, Lilly, Novartis, Pfizer, Merck, BMS, MSD, Roche, Boehringer Ingelheim, Amgen, Illumina, Janssen and has research funding from Roche, BMS, MSD, Bruker and AZ. NP served as a speaker for Thermo Fisher Scientific, Illumina, BMS, and Roche Diagnostics and has attended the Advisory Board for Novartis. All remaining authors declare no competing interests.